Used in research for the treatment of HIV infection, specifically as a non-nucleoside reverse transcriptase inhibitor (NNRTI). It works by blocking the activity of the reverse transcriptase enzyme, which is essential for viral replication. Although it showed antiviral activity in early studies, development was limited due to issues with solubility and variable efficacy in clinical trials. It remains a compound of interest in understanding drug resistance mechanisms in HIV therapy.